E. Schatz - Correlation and hep c project.ppt. Schatz... · Overall aim “Improving the access to...

Overall aim“Improving the access to and the quality of health and social services for marginalised

people”

To tackle health inequalities and to improve prevention, care and treatment services,

targeting blood-borne infectious diseases (BBID’s), in particular Hepatitis C and HIV/AIDS

among vulnerable and high risk populations

Why?

�Acces to health services is limited

�Quality of services is not sufficiant

�Policies are not targeted

Health problems of marginalised groups and people are a threat for public health and welfare !

How?

�Creating a platform for mutual exchange

�Collecting and reviewing existing evidence

�Implementing innovative approaches

�Addressing the policy level: Translation of outcomes and results towards the policy level

DPIP project 2013/14

� 30 partner from 15 countries� 08 universities / health institutes� 15 service provider (NGO's)� 02 drug user organisations� 05 European Networks

� Observer: EMCDDA, ECDC, WHO

Partner

� improve knowledge� improve capacities� Influence policies

Aims

� WS 0 Coordination FRG� WS 1 Evaluation CIAR� WS 2 Inventory CIAR� WS 3 Peer training SDUU� WS 4 Literature review CHIP� WS 5 Policy & Advocacy APDES

Working streams

Liver or Die

To inform and to be informed

To learn and to teach

Ett projekt som drivs av

Svenska Brukarföreningen,

med stöd av Smittskyddsinstitutet

Feedback

– hard to access young drug user

– lack of competence of health care professionals to communicate with patients

– test kits not available

– wrong information: cut and paste from HIV info

- great need of hep c support groups

- systemic barriers: opening/appointment hours

– no services on the country side

– fear of side effects – no information or only negative ones

– waiting lists for access

– active drug user are not treated, alcohol sober for 2 years

– no national guidelines, every hospital has own approach

Workstream 2

Inventory of effective interventions

Rationale

* Testing for HCV and referral to HCV treatment are key interventions

* In practice testing rates are low, except from substitution treatment

* PWUD are often not aware about risk of HCV infection

* Low-threshold services assume that most PWUD are tested in prison

THUS

HCV testing needs to be increased in particular in low-threshold services

Guidelines

Compilation of the most recent guidelines for HCV testing and

antiviral treatment

Aim

Guidelines as indicators for assessment and evaluation of

good practice in HCV testing, pre- and post-test counselling

and referral to treatment services

Delivered to active drug users

Interviews –drug users

Interviews with 50 clients of the low-threshold drug services

Method: Structured questionnaire

Access: through services that participate in the monitoring

Topics:

risk awareness and risk behaviour

previous HCV testing

willingness to uptake HCV testing

experiences with pre- and post-test counselling

acceptance of HCV treatment

Interviews staff

In services which implemented the monitoring toolQualitative face-to-face interviews

Objective> To identify possibles barrierrs barriers to testing and referral to treatment

at different levels> Structure - limited staff> Economic – limited funding for testing> Individual – clients not want to get tested

� Study results and toolkit� Toolkit with templates� 4 national events: Portugal, Finland, Germany, Romania

Results

� resource centre� peer training manual� policy & advocacy strategy� Literature review� Study results and toolkit

Results

Activities:

1. Mapping, analyzing and comparing existing national and European Hepatitis C action plans, strategies, recommendations and guidelines.

2. Development and implementation of 1 European and 4 national advocacy strategies.

3. Organising 1 European Parliamentary meeting and 4 national policy dialogue meetings.

4. Setting up a sustainable ‘Hepatitis C and drug use’ platform of experts and stakeholders.

Workstream Policy

� Facebook campaign� Hepatitis policy event EP, autumn 2014� final conference Berlin, October 2014

Next year

www.hepatitis-c-initiative.eu

Get involved !eschatz@correlation-net.org